Senseonics Holdings, Inc. is a medical technology company that provides continuous glucose monitoring systems for people living with diabetes across various regions globally. The company's products, Eversense and Eversense XL, are known to measure glucose levels by using under-the-skin sensors and a smart transmitter linked to a mobile app that enables real-time monitoring and management for up to six months. Senseonics Holdings, Inc. offers its products and services through distributors, strategic fulfillment partners, and has a collaboration agreement with the University Hospitals Accountable Care Organization.